Patient Presentation
16
-
Upload
tashya-combs -
Category
Documents
-
view
20 -
download
1
description
Patient Presentation. 2013 ACC/AHA Cholesterol Guidelines 4 Major Statin Benefit Groups. Timelines of Lipid-Lowering Agents. Evolution of Therapeutic Monoclonal Antibodies. PCSK9 Inhibition in Patients With Hypercholesterolemia Receiving Statin Therapy. - PowerPoint PPT Presentation
Transcript of Patient Presentation
![Page 1: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/1.jpg)
![Page 2: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/2.jpg)
Patient Presentation
![Page 3: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/3.jpg)
2013 ACC/AHA Cholesterol Guidelines
4 Major Statin Benefit Groups
![Page 4: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/4.jpg)
![Page 5: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/5.jpg)
Timelines of Lipid-Lowering Agents
![Page 6: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/6.jpg)
Evolution of Therapeutic Monoclonal Antibodies
![Page 7: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/7.jpg)
![Page 8: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/8.jpg)
PCSK9 Inhibition in Patients With Hypercholesterolemia Receiving
Statin Therapy
![Page 9: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/9.jpg)
Effect of PCSK9-Inhibitor Monotherapy on Lipid Parameters
![Page 10: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/10.jpg)
Clinical Considerations for PCSK9 Inhibitors
![Page 11: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/11.jpg)
Abbreviations
![Page 12: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/12.jpg)
Abbreviations (cont)
![Page 13: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/13.jpg)
References
![Page 14: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/14.jpg)
References (cont)
![Page 15: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/15.jpg)
References (cont)
![Page 16: Patient Presentation](https://reader036.fdocuments.us/reader036/viewer/2022062718/56812cad550346895d915d4b/html5/thumbnails/16.jpg)
References (cont)